NEW YORK – The US Food and Drug Administration on Tuesday issued Emergency Use Authorization to UCLA's SwabSeq COVID-19 Diagnostic Platform for detecting SARS-CoV-2.
The device is for the qualitative detection of the coronavirus in nasopharyngeal swabs, oropharyngeal swabs, mid-turbinate nasal swabs, and anterior nasal swabs from individuals who are suspected of having COVID-19, the disease caused by SARS-CoV-2.